P510 Assessment of study group – patients with inflammatory bowel disease, treated with monoclonal anti-TNF alpha: a multicent
Y-ECCO on Twitter: "#ECCO21 late online registration deadline approaching! June 16, 2021 ECCO'21 Congress website: https://t.co/MXbpmTeOcn Discover the Scientific programme: https://t.co/FX5yTfZGQM and the Educational programme: https://t.co/IUKWRjV32T ...
![12th Congress of ECCO - Congresses & Events - Events - Events & Newsroom - The European Society of Pathology 12th Congress of ECCO - Congresses & Events - Events - Events & Newsroom - The European Society of Pathology](https://www.esp-pathology.org/_Resources/Persistent/ac53b796218c5b837763c09492b2107fa2791497/170907_v2_ECCO%2717%20Web%20banner_150x100.jpg)
12th Congress of ECCO - Congresses & Events - Events - Events & Newsroom - The European Society of Pathology
![PDF) P373 Real-file prospective experience with adalimumab in inducing remission in ulcerative colitis in Italian primary inflammatory bowel diseases centres PDF) P373 Real-file prospective experience with adalimumab in inducing remission in ulcerative colitis in Italian primary inflammatory bowel diseases centres](https://i1.rgstatic.net/publication/313469406_P373_Real-file_prospective_experience_with_adalimumab_in_inducing_remission_in_ulcerative_colitis_in_Italian_primary_inflammatory_bowel_diseases_centres/links/5a7c8356aca272669a2ce817/largepreview.png)